Protected: Tecentriq® (atezolizumab) and Avastin® (bevacizumab) combination now reimbursed for Australians living with the most common form of liver cancer
This content is password protected. To view it please enter your password below: Password:
Browsing: Tecentriq
The Oncology Journal Club Episode 12
In this week’s episode of The Oncology Journal Club, our host Eva Segelov talks us…
Protected: TECENTRIQ® (atezolizumab) first immunotherapy to be reimbursed for 1L treatment of extensive-stage small cell lung cancer
This content is password protected. To view it please enter your password below: Password:
Protected: Immunotherapy combination now PBS listed for first-line treatment of metastatic non-squamous non-small cell lung cancer (1,2)
This content is password protected. To view it please enter your password below: Password:
Protected: Tecentriq® (atezolizumab) + chemotherapy now TGA approved for 1L extensive-stage small cell lung cancer
This content is password protected. To view it please enter your password below: Password: